109 related articles for article (PubMed ID: 10477813)
1. Rotating dialysis cell as in vitro release method for oily parenteral depot solutions.
Schultz K; Møllgaard B; Frokjaer S; Larsen C
Int J Pharm; 1997 Nov; 157(2):163-169. PubMed ID: 10477813
[TBL] [Abstract][Full Text] [Related]
2. Assessment of drug release from oil depot formulations using an in vitro model -- potential applicability in accelerated release testing.
Larsen SW; Jessen MN; Ostergaard J; Larsen C
Drug Dev Ind Pharm; 2008 Mar; 34(3):297-304. PubMed ID: 18363145
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration.
Larsen SW; Østergaard J; Friberg-Johansen H; Jessen MN; Larsen C
Eur J Pharm Sci; 2006 Dec; 29(5):348-54. PubMed ID: 16920337
[TBL] [Abstract][Full Text] [Related]
4. In vitro dissolution testing of parenteral aqueous solutions and oily suspensions of paracetamol and prednisolone.
Probst M; Schmidt M; Tietz K; Klein S; Weitschies W; Seidlitz A
Int J Pharm; 2017 Oct; 532(1):519-527. PubMed ID: 28935252
[TBL] [Abstract][Full Text] [Related]
5. Modification of in vitro drug release rate from oily parenteral depots using a formulation approach.
Fredholt K; Larsen DH; Larsen C
Eur J Pharm Sci; 2000 Sep; 11(3):231-7. PubMed ID: 11042229
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of drug substances in oily solutions. Drug release rate, partitioning and solubility.
Larsen DB; Parshad H; Fredholt K; Larsen C
Int J Pharm; 2002 Jan; 232(1-2):107-17. PubMed ID: 11790494
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration.
Pedersen BT; Larsen SW; Østergaard J; Larsen C
Drug Deliv; 2008 Jan; 15(1):23-30. PubMed ID: 18197520
[TBL] [Abstract][Full Text] [Related]
8. Assessment of rate of drug release from oil vehicle using a rotating dialysis cell.
Larsen DH; Fredholt K; Larsen C
Eur J Pharm Sci; 2000 Sep; 11(3):223-9. PubMed ID: 11042228
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the rotating dialysis cell as an in vitro model potentially useful for simulation of the pharmacokinetic fate of intra-articularly administered drugs.
Pedersen BT; Ostergaard J; Larsen SW; Larsen C
Eur J Pharm Sci; 2005 May; 25(1):73-9. PubMed ID: 15854803
[TBL] [Abstract][Full Text] [Related]
10. Beyond Q1/Q2: The Impact of Manufacturing Conditions and Test Methods on Drug Release From PLGA-Based Microparticle Depot Formulations.
Garner J; Skidmore S; Park H; Park K; Choi S; Wang Y
J Pharm Sci; 2018 Jan; 107(1):353-361. PubMed ID: 29107048
[TBL] [Abstract][Full Text] [Related]
11. USP Apparatus 4: a Valuable In Vitro Tool to Enable Formulation Development of Long-Acting Parenteral (LAP) Nanosuspension Formulations of Poorly Water-Soluble Compounds.
Forrest WP; Reuter KG; Shah V; Kazakevich I; Heslinga M; Dudhat S; Patel S; Neri C; Mao Y
AAPS PharmSciTech; 2018 Jan; 19(1):413-424. PubMed ID: 28755052
[TBL] [Abstract][Full Text] [Related]
12. Long-acting contraceptive agents: the influence of physico-chemical properties of some esters of norethisterone upon the plasma levels of free norethisterone.
Enever RP; Fotherby K; Naderi S; Lewis GA
Steroids; 1983 Mar; 41(3):381-96. PubMed ID: 6658883
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots.
Probst M; Kühn JP; Scheuch E; Seidlitz A; Hadlich S; Evert K; Oswald S; Siegmund W; Weitschies W
J Control Release; 2016 Apr; 227():1-12. PubMed ID: 26899995
[TBL] [Abstract][Full Text] [Related]
14. A novel in vitro release method for submicron sized dispersed systems.
Chidambaram N; Burgess DJ
AAPS PharmSci; 1999; 1(3):E11. PubMed ID: 11741207
[TBL] [Abstract][Full Text] [Related]
15. A New Method for Evaluating Actual Drug Release Kinetics of Nanoparticles inside Dialysis Devices via Numerical Deconvolution.
Zhou Y; He C; Chen K; Ni J; Cai Y; Guo X; Wu XY
J Control Release; 2016 Dec; 243():11-20. PubMed ID: 27693750
[TBL] [Abstract][Full Text] [Related]
16. Bupivacaine salts of diflunisal and other aromatic hydroxycarboxylic acids: aqueous solubility and release characteristics from solutions and suspensions using a rotating dialysis cell model.
Østergaard J; Larsen SW; Parshad H; Larsen C
Eur J Pharm Sci; 2005 Nov; 26(3-4):280-7. PubMed ID: 16087321
[TBL] [Abstract][Full Text] [Related]
17. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS).
Friedrich I; Reichl S; Müller-Goymann CC
Int J Pharm; 2005 Nov; 305(1-2):167-75. PubMed ID: 16242276
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, sterility validation, and in vitro cell toxicity studies of microemulsions possessing potential parenteral applications.
Nesamony J; Zachar CL; Jung R; Williams FE; Nauli S
Drug Dev Ind Pharm; 2013 Feb; 39(2):240-51. PubMed ID: 22480266
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular injection of morphine to the horse: establishment of an in vitro-in vivo relationship.
Frost AB; Lindegaard C; Larsen F; Østergaard J; Larsen SW; Larsen C
Drug Dev Ind Pharm; 2011 Sep; 37(9):1043-8. PubMed ID: 21417608
[TBL] [Abstract][Full Text] [Related]
20. Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition.
Yaghmur A; Rappolt M; Østergaard J; Larsen C; Larsen SW
Langmuir; 2012 Feb; 28(5):2881-9. PubMed ID: 22247936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
